Fennec Pharmaceuticals Inc (FENC)
R&D Expense Growth
140.82%
Quarterly · Period ending:
FENC R&D Expense Growth
Latest reported140.82%period ending
Latest reported140.82%period ending
FENC Quarterly R&D Growth (QoQ) (0.00% → 140.82%)
Latest values, visible window
High-resolution chart · PNG
FENC r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 140.8163% | |
| 145% | |
| -31.0345% | |
| -72.8972% | |
| 13.8298% | |
| 88% | |
| -48.4536% | |
| -38.2166% | |
| 5,133.3333% | |
| -90.625% | |
| 166.6667% | |
| 50% | |
| 100% | |
| -96.5812% | |
| -86.1702% | |
| -25.1989% | |
| -21.2944% | |
| 174.761% | |
| -57.8905% | |
| 55.25% | |
| -66.8874% | |
| 97.547% | |
| -10.5994% | |
| 22.0339% | |
| -19.5262% | |
| 18.8567% | |
| 47.4214% | |
| -59.6242% | |
| 17.8336% | |
| -3.018% | |
| -4.1713% | |
| 125.3133% | |
| 15.82% | |
| -22.2348% | |
| 80.0813% | |
| 47.7477% | |
| 48% | |
| 29.3103% | |
| 55.3571% | |
| -19.4245% | |
| 195.7447% | |
| -33.8028% | |
| -19.3182% | |
| 62.963% | |
| 25.5814% | |
| -73.9394% | |
| 87.5% | |
| 22.2222% | |
| 125% | |
| -64.4444% | |
| 140.1786% | |
| -140.4332% | |
| 211.236% | |
| -68.2709% | |
| 57.1429% | |
| -58.4884% | |
| 190.5405% | |
| -41.502% | |
| 15.262% | |
| 87.6068% | |
| -25.7143% | |
| 8.9965% | |
| 162.7273% | |
| -24.6575% | |
| -10.4294% | |
| 18.9781% | |
| 191.4894% | |
| -92.7692% | |
| -49.179% | |
| -19.9625% | |
| -43.3534% | |
| 9.6812% | |
| -23.7926% | |
| 28.866% | |
| 5.1807% | |
| -5.8957% | |
| -16.1863% | |
| -22.6048% | |
| -0.4135% | |
| 25.3366% | |
| 27.6563% | |
| -34.6345% | |
| 24.4563% | |
| -6.3476% | |
| 66.5091% | |
| 43.936% | |
| 9.0183% | |
| 41.2883% | |
| -23.1767% | |
| 35.3081% | |
| 42.4973% | |
| -43.0503% | |
| 57.74% | |
| -2.5893% | |
| -26.3667% | |
| -22.538% | |
| 74.1667% | |
| 42.4168% | |
| -30.0677% | |
| 0% |